B
0.690
0.06 (9.46%)
| Penutupan Terdahulu | 0.630 |
| Buka | 0.651 |
| Jumlah Dagangan | 17,500 |
| Purata Dagangan (3B) | 86,270 |
| Modal Pasaran | 12,958,411 |
| Harga / Jualan (P/S) | 1.32 |
| Harga / Buku (P/B) | 3.07 |
| Julat 52 Minggu |
| Margin Keuntungan | 4.28% |
| Margin Operasi (TTM) | -11.31% |
| EPS Cair (TTM) | 0.010 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -1.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -36.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 74.26% |
| Nisbah Semasa (MRQ) | 1.88 |
| Aliran Tunai Operasi (OCF TTM) | -1.42 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 11.22 M |
| Pulangan Atas Aset (ROA TTM) | -1.21% |
| Pulangan Atas Ekuiti (ROE TTM) | 6.10% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Care Facilities (US) | Menaik | Bercampur |
| Medical Care Facilities (Global) | Menaik | Menaik | |
| Stok | Basel Medical Group Ltd | - | - |
AISkor Stockmoo
0.5
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.50 |
|
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore. |
|
| Sektor | Healthcare |
| Industri | Medical Care Facilities |
| % Dimiliki oleh Orang Dalam | 67.81% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Coston, Mcisaac & Partners | 31 Dec 2025 | 50 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 23 Jan 2026 | Pengumuman | Receipt of Delinquency Notification from Nasdaq |
| 01 Dec 2025 | Pengumuman | Receipt of Delinquency Notification from Nasdaq |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |